These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 29973488)

  • 1. Advances in Pharmaceutical Strategies Enhancing the Efficiencies of Oral Colon-Targeted Delivery Systems in Inflammatory Bowel Disease.
    Guo Y; Zong S; Pu Y; Xu B; Zhang T; Wang B
    Molecules; 2018 Jul; 23(7):. PubMed ID: 29973488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug delivery strategies in the therapy of inflammatory bowel disease.
    Lautenschläger C; Schmidt C; Fischer D; Stallmach A
    Adv Drug Deliv Rev; 2014 May; 71():58-76. PubMed ID: 24157534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial anti-inflammatory effect of paeonol self-microemulsion-loaded colon-specific capsules on experimental ulcerative colitis rats.
    Zong S; Pu Y; Li S; Xu B; Zhang Y; Zhang T; Wang B
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):324-335. PubMed ID: 29316822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug delivery strategies for targeted treatment of inflammatory bowel disease].
    Lautenschläger C; Schmidt C; Lange K; Stallmach A
    Z Gastroenterol; 2015 Mar; 53(3):226-34. PubMed ID: 25723326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: selective targeting to diseased versus healthy tissue.
    Hua S; Marks E; Schneider JJ; Keely S
    Nanomedicine; 2015 Jul; 11(5):1117-32. PubMed ID: 25784453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colon-targeted drug delivery of polysaccharide-based nanocarriers for synergistic treatment of inflammatory bowel disease: A review.
    Cui M; Zhang M; Liu K
    Carbohydr Polym; 2021 Nov; 272():118530. PubMed ID: 34420762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral colon-specific therapeutic approaches toward treatment of inflammatory bowel disease.
    Xiao B; Merlin D
    Expert Opin Drug Deliv; 2012 Nov; 9(11):1393-407. PubMed ID: 23036075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticle-Mediated Drug Delivery Systems For The Treatment Of IBD: Current Perspectives.
    Yang C; Merlin D
    Int J Nanomedicine; 2019; 14():8875-8889. PubMed ID: 32009785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Size-dependent nanoparticulate drug delivery in inflammatory bowel diseases.
    Youshia J; Lamprecht A
    Expert Opin Drug Deliv; 2016; 13(2):281-94. PubMed ID: 26637060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New targeting strategies in drug therapy of inflammatory bowel disease: mechanistic approaches and opportunities.
    Wolk O; Epstein S; Ioffe-Dahan V; Ben-Shabat S; Dahan A
    Expert Opin Drug Deliv; 2013 Sep; 10(9):1275-86. PubMed ID: 23721560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In situ self-spray coating system that can uniformly disperse a poorly water-soluble H
    Lin WC; Pan WY; Liu CK; Huang WX; Song HL; Chang KS; Li MJ; Sung HW
    Biomaterials; 2018 Nov; 182():289-298. PubMed ID: 30144577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current pharmaceutical strategies for efficient site specific delivery in inflamed distal intestinal mucosa.
    Sharma S; Sinha VR
    J Control Release; 2018 Feb; 272():97-106. PubMed ID: 29317245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colon targeted oral drug delivery system based on alginate-chitosan microspheres loaded with icariin in the treatment of ulcerative colitis.
    Wang QS; Wang GF; Zhou J; Gao LN; Cui YL
    Int J Pharm; 2016 Dec; 515(1-2):176-185. PubMed ID: 27713029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The future of nanomedicine in optimising the treatment of inflammatory bowel disease.
    Mohan LJ; Daly JS; Ryan BM; Ramtoola Z
    Scand J Gastroenterol; 2019 Jan; 54(1):18-26. PubMed ID: 30678499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
    Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
    Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease.
    Zhang S; Ermann J; Succi MD; Zhou A; Hamilton MJ; Cao B; Korzenik JR; Glickman JN; Vemula PK; Glimcher LH; Traverso G; Langer R; Karp JM
    Sci Transl Med; 2015 Aug; 7(300):300ra128. PubMed ID: 26268315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Insights of Oral Colonic Drug Delivery Systems for Inflammatory Bowel Disease Therapy.
    Teruel AH; Gonzalez-Alvarez I; Bermejo M; Merino V; Marcos MD; Sancenon F; Gonzalez-Alvarez M; Martinez-Mañez R
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting strategies of oral nano-delivery systems for treating inflammatory bowel disease.
    Liu W; Dong Z; Liu K; Lu Y; Wu W; Qi J; Chen Z
    Int J Pharm; 2021 May; 600():120461. PubMed ID: 33711470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral hydrogel nanoemulsion co-delivery system treats inflammatory bowel disease via anti-inflammatory and promoting intestinal mucosa repair.
    Lei F; Zeng F; Yu X; Deng Y; Zhang Z; Xu M; Ding N; Tian J; Li C
    J Nanobiotechnology; 2023 Aug; 21(1):275. PubMed ID: 37596598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model.
    Laroui H; Dalmasso G; Nguyen HT; Yan Y; Sitaraman SV; Merlin D
    Gastroenterology; 2010 Mar; 138(3):843-53.e1-2. PubMed ID: 19909746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.